Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 4/20 | 0.49 |
| ▸ | ELANE | P08246 | 2/20 | 0.49 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TACR1 | P25103 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 3/20 | 0.47 |
| ▸ | CTSS | P25774 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5552090 | 0.87 | CTSL (0.52) | CTSKELANEPRTN3LMNATACR1 | |
| SCHEMBL5552094 | 0.87 | CTSL (0.52) | CTSKELANEPRTN3LMNATACR1 | |
| SCHEMBL5552099 | 0.87 | CTSL (0.52) | CTSKELANEPRTN3LMNATACR1 | |
| SCHEMBL5660606 | 0.87 | CTSL (0.52) | CTSKELANEPRTN3LMNATACR1 | |
| SCHEMBL16059281 | 0.86 | ATM (0.53) | CTSKELANEPRTN3CTSLCTSS | |
| SCHEMBL16059278 | 0.86 | ATM (0.53) | CTSKELANEPRTN3CTSLCTSS | |
| SCHEMBL22370935 | 0.86 | ATM (0.53) | CTSKELANEPRTN3CTSLCTSS | |
| SCHEMBL21749693 | 0.83 | LMNA (0.52) | NPC1RAB9ALMNAPOLBATM | |
| SCHEMBL14384536 | 0.83 | MAPK14 (0.49) | NPC1RAB9ALMNAPOLB | |
| SCHEMBL4679410 | 0.82 | TACR1 (0.52) | CTSKELANEPRTN3NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2024-02-29 | — | — | US | claimed |
| US-12310365-B2 | Plant disease control composition and method for controlling plant disease by applying the same | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2025-05-27 | — | — | US | disclosed |
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-11805779-B2 | Plant disease control composition and method for controlling plant disease by applying the same | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2023-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | SNX1, HAX1, BROX | CTSK 2703/4885ELANE 3623/4885PRTN3 258/4885 |
| US-12310365-B2 | Plant disease control composition and method for controlling plant disease by applying the same | SNX1, HAX1, BROX | CTSK 2703/4885ELANE 3623/4885PRTN3 258/4885 |
| US-11805779-B2 | Plant disease control composition and method for controlling plant disease by applying the same | SNX1, HAX1, BROX | CTSK 2703/4885ELANE 3623/4885PRTN3 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.